Education
About Us
Working with TipRanks
Follow Us
Christian Rigg Insider Profile
4 Followers
Christian Rigg, Executive at Clinigen, holds 1.61K shares in Clinigen (Ticker: GB:CLIN). Most recently, Christian Rigg Sold 4,955p shares of Clinigen on Nov 24, 2017 for an estimated value of 50.39K.
Christian Rigg Clinigen (CLIN)Executive
Clinigen (CLIN)
Executive
Not Ranked
Christian Rigg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Christian Rigg does not currently own shares as a corporate insider.
A breakdown of Christian Rigg's holdings
Insider Roles
Christian Rigg does not currently hold a role as a corporate insider.
Roles that Christian Rigg holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christian Rigg
Christian Rigg's Trading History
List of latest transactions for each holding click on a transaction to see Christian Rigg's performance on stock
You May Also Like
Christian Rigg insider profile FAQ
What is the percentage of profitable transactions made by Christian Rigg?
The percentage of profitable transactions made by Christian Rigg is ―.
What is the average return per transaction made by Christian Rigg?
The average return per transaction made by Christian Rigg is ―.
What stocks does Christian Rigg hold?
Christian Rigg holds: GB:CLIN stocks.
What was Christian Rigg’s latest transaction?
Christian Rigg latest transaction was an Informative Sell of 50.39K.
What was Christian Rigg's most profitable transaction?
Christian Rigg’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christian Rigg's role in Clinigen?
Christian Rigg's role in Clinigen is Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.